Effect of montelukast on symptoms and exhaled nitric oxide levels in 7- to 14-year-old children with seasonal allergic rhinitis (Q79481168)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17201236%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

title

Effect of montelukast on symptoms and exhaled nitric oxide levels in 7- to 14-year-old children with seasonal allergic rhinitis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17201236%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

1 reference

seasonal allergic rhinitis

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17201236%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

author name string

Arzu Bakirtas

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17201236%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Koray Harmanci

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17201236%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Ipek Turktas

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17201236%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

Deniz Erbas

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17201236%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

publication date

1 December 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17201236%20AND%20SRC:MED&resulttype=core&format=json

Annals of Allergy, Asthma & Immunology

23 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17201236%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

volume

97

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17201236%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17201236%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

page(s)

767-774

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17201236%20AND%20SRC:MED&resulttype=core&format=json

Prevalence and impact of multiple childhood chronic illnesses

23 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960968-4

7 January 2021

Clinical evidence for antileukotriene therapy in the management of allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960968-4

7 January 2021

Montelukast improves symptoms of seasonal allergic rhinitis over a 4‐week treatment period

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960968-4

7 January 2021

Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the spring

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960968-4

7 January 2021

The effect of montelukast on rhinitis symptoms in patients with asthma and seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960968-4

7 January 2021

Randomized controlled trial evaluating the clinical benefit of montelukast for treating spring seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960968-4

7 January 2021

Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960968-4

7 January 2021

Montelukast plus cetirizine in the prophylactic treatment of seasonal allergic rhinitis: influence on clinical symptoms and nasal allergic inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960968-4

7 January 2021

Nitric oxide and asthmatic inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960968-4

7 January 2021

Increased exhaled nitric oxide in asthma is mainly derived from the lower respiratory tract

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960968-4

7 January 2021

Exhaled nitric oxide in seasonal allergic rhinitis: influence of pollen season and therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960968-4

7 January 2021

A comparison of once daily fexofenadine versus the combination of montelukast plus loratadine on domiciliary nasal peak flow and symptoms in seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960968-4

7 January 2021

Influence of atopy on exhaled nitric oxide in patients with stable asthma and rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960968-4

7 January 2021

Effect of nasal triamcinolone acetonide on lower airway inflammatory markers in patients with allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960968-4

7 January 2021

Measurement of exhaled nitric oxide in children, 2001.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960968-4

7 January 2021

Do the leukotriene receptor antagonists work in children with grass pollen-induced allergic rhinitis?

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960968-4

7 January 2021

Circulating eosinophil/basophil progenitors and nasal mucosal cytokines in seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960968-4

7 January 2021

Nasal response to a single antigen challenge in patients with allergic rhinitis - inflammatory cell recruitment persists up to 48 hours

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960968-4

7 January 2021

Basophil histamine release, IgE, eosinophil counts, ECP, and EPX are related to the severity of symptoms in seasonal allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960968-4

7 January 2021

Hypodense eosinophils in allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960968-4

7 January 2021

Montelukast for chronic asthma in 6- to 14-year-old children: a randomized, double-blind trial. Pediatric Montelukast Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960968-4

7 January 2021

Montelukast, a once-daily leukotriene receptor antagonist, in the treatment of chronic asthma: a multicenter, randomized, double-blind trial. Montelukast Clinical Research Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960968-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960968-4

7 January 2021

Interrelationships among asthma, atopy, rhinitis and exhaled nitric oxide in a population‐based sample of children

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960968-4

7 January 2021

Increased levels of exhaled nitric oxide during nasal and oral breathing in subjects with seasonal rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960968-4

7 January 2021

Exhaled and nasal NO levels in allergic rhinitis: relation to sensitization, pollen season and bronchial hyperresponsiveness

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960968-4

7 January 2021

The role of leukotrienes in allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960968-4

7 January 2021

Concentrations of exhaled nitric oxide in asthmatics and subjects with allergic rhinitis sensitized to the same pollen allergen

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960968-4

7 January 2021

Modifications of airway responsiveness to adenosine 5'-monophosphate and exhaled nitric oxide concentrations after the pollen season in subjects with pollen-induced rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960968-4

7 January 2021

Exhaled nitric oxide and bronchial responsiveness to adenosine 5'-monophosphate in subjects with allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960968-4

7 January 2021

Relationship between exhaled nitric oxide and atopy in Asian young adults

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960968-4

7 January 2021

Antiasthmatic effects of mediator blockade versus topical corticosteroids in allergic rhinitis and asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960968-4

7 January 2021

A comparison of topical budesonide and oral montelukast in seasonal allergic rhinitis and asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960968-4

7 January 2021

Exhaled nitric oxide, total serum IgE and allergic sensitization in childhood asthma and allergic rhinitis

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960968-4

7 January 2021

Correlation between exhaled nitric oxide, sputum eosinophils, and methacholine responsiveness in patients with mild asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960968-4

7 January 2021

A comparison of exhaled nitric oxide and induced sputum as markers of airway inflammation

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960968-4

7 January 2021

Neutrophilic inflammation in severe persistent asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960968-4

7 January 2021

Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in mild to moderately severe asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960968-4

7 January 2021

Correlation of exhaled nitric oxide levels and airway inflammation markers in stable asthmatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2960968-4

7 January 2021

10.1016/S1081-1206(10)60968-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17201236%20AND%20SRC:MED&resulttype=core&format=json

23 December 2019

1 reference